Allergy Therapeutics plc (AIM: AGY)

Allergy Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	205	7	134	160	89	89
Market Cap Growth	180.75%	-94.66%	-16.71%	80.14%	0%	-46.93%
Enterprise Value	201	2	102	124	60	60
Last Close Price	0.04	0.00	0.10	0.12	0.06	0.06
PE Ratio	-	-0.08	-4.46	26.77	6.14	12.39
PS Ratio	1.37	0.12	1.84	1.90	1.14	1.21
PB Ratio	7.75	3.45	3.54	3.31	2.03	2.37
P/FCF Ratio	-3.27	-0.21	-7.83	26.62	8.71	31.92
P/OCF Ratio	-3.70	-0.25	-9.54	18.68	7.13	15.90
EV/Sales Ratio	3.78	0.03	1.40	1.47	0.77	0.82
EV/EBITDA Ratio	-3.79	-0.05	-9.98	20.31	8.45	-60177.61
EV/EBIT Ratio	-3.59	-0.05	-8.26	31.62	12.08	-32.78
EV/FCF Ratio	-5.52	-0.05	-5.99	20.60	5.90	21.57
Debt / Equity Ratio	0.37	17.42	0.28	0.23	0.28	0.06
Debt / EBITDA Ratio	-	-	-	1.44	1.41	-
Debt / FCF Ratio	-0.27	-1.07	-0.62	1.85	1.19	0.87
Asset Turnover	0.76	0.85	0.90	0.97	1.01	1.23
Inventory Turnover	2.21	2.29	2.09	2.11	2.07	2.02
Quick Ratio	0.93	1.07	1.46	2.46	2.34	2.13
Current Ratio	1.40	1.81	2.35	3.17	3.03	2.77
Return on Equity (ROE)	-155.90%	-216.27%	-31.93%	6.25%	17.35%	11.44%
Return on Assets (ROA)	-34.76%	-31.48%	-9.60%	2.82%	4.03%	-1.92%
Return on Capital (ROIC)	-58.18%	-50.94%	-14.32%	4.24%	6.50%	-3.47%
Earnings Yield	-68.89%	-604.03%	-10.31%	1.80%	7.92%	3.89%
FCF Yield	-17.80%	-470.51%	-12.76%	3.76%	11.48%	3.13%
Buyback Yield / Dilution	-160.33%	-4.26%	4.98%	-0.47%	-0.57%	-12.54%
Total Shareholder Return	-160.33%	-4.26%	4.98%	-0.47%	-0.57%	-12.54%

Source: S&P Capital IQ. Standard template. Financial Sources.